9–11 Oct 2023
Mercure Hotel MOA Berlin
Europe/Berlin timezone

Comparison of human- and rat-derived strains of rat hepatitis E virus in cell lines of both hosts

11 Oct 2023, 13:45
15m
MOA 6

MOA 6

Oral presentation Zoonoses & Wildlife Session 12: Zoonoses & Wildlife II

Speaker

Jessica Panajotov (Bundeinstitut für Risikobewertung)

Description

Rat hepatitis E virus (ratHEV) is distantly related to the well-studied human-pathogenic HEV genotypes 1-4 and distributed in rats worldwide. Recently, ratHEV infection has been demonstrated in several hepatitis cases in human patients from Hongkong, Canada and Spain. To characterize rat- and human-derived ratHEV strains in more detail, we generated genomic plasmids, which were in-vitro transcribed, capped and transfected into human hepatoma cell lines to generate infectious virus. One ratHEV strain was derived from a hepatitis patient from Hongkong, the other from a rat in Germany, and a human genotype 3 strain served as a control. Virus replication was evident for all viruses in all transfected cell lines. However, it was most robust in Huh7-Lunet BLR cells, which could also be passaged resulting in persistently infected and virus-producing cell lines. The generated viruses were used to infect human-derived PLC/PRF/5, Huh7 and Huh7-Lunet BLR hepatoma cell lines as well as rat-derived hepatoma cell lines MH1C1, clone 9 and H4IIE. All of the viruses replicated in the human cell lines, but showed no stable infection of the rat-derived cell lines. The ratHEV strain from the human patient showed a more efficient replication in the human cells as compared to the rat-derived strain, which may indicate a better adaptation to humans. Generally, the results show robust replication of ratHEV in human cell lines, which confirm its zoonotic potential for transmission to humans.

Keywords

cell culture; ratHEV; zoonotic potential; reversed genetics system; HEV

Registration-ID code ZOO23-505
Professional Status of the Speaker PhD Student
Junior Scientist Status Yes, I am a Junior Scientist.

Primary author

Jessica Panajotov (Bundeinstitut für Risikobewertung)

Co-authors

Dr Alexander Falkenhagen (Bundesinstitut für Risikobewertung) Mr Mathias Schemmerer (2National Consultant Laboratory for HAV and HEV, Institute of Clinical Microbiology and Hygiene, University Medical Center Regensburg, Regensburg, Germany) Prof. Reimar Johne (Bundesinstitut für Risikobewertung)

Presentation materials

There are no materials yet.

External references

Peer reviewing

Paper